Court, Explained
U.S. Federal District Courts
←Back to docket
S.D.N.Y.Procedural orderFiled June 25, 2020

Blume v. Port Authority Trans-Hudson Corporation

Judge
Colleen McMahon
Docket
1:18-cv-12251
Court
U.S. District Court · Southern District of New York
Pages
3
Civil ProcedureTort
In one sentence

In Blume v. Port Authority Trans-Hudson Corporation, Chief Judge McMahon denied PATH’s reconsideration motion, leaving summary judgment unresolved.

Who this affects

PATH’s reconsideration motion was denied, so the court’s earlier denial of summary judgment remained in place for Thomas Blume and Jason Martinez’s case.

What happened

In Blume v. Port Authority Trans-Hudson Corporation, PATH asked the court to reconsider its earlier order denying PATH’s request for summary judgment in Thomas Blume and Jason Martinez’s toxic-exposure case. The earlier order allowed the case to continue.

PATH repeated arguments that expert testimony was required to prove causation and that the plaintiffs’ evidence, including testimony and medical records, was insufficient. The court explained that those arguments did not meet the strict standard for reconsideration and conflicted with Second Circuit law allowing causation to be shown without expert testimony in some circumstances.

Chief Judge Colleen McMahon denied PATH’s motion for reconsideration and directed the clerk to close that motion. The opinion did not change the earlier denial of summary judgment.

The detailed version

For law students, journalists, and other readers who want the full reasoning

Case
Blume v. Port Authority Trans-Hudson Corporation · No. 1:18-cv-12251
Judge
Colleen McMahon
Date
June 25, 2020

Background

Defendant Port Authority Trans-Hudson Corporation, referred to as PATH, moved for reconsideration of the court’s April 6, 2020 order denying PATH’s motion for summary judgment. The earlier order concerned claims by Thomas Blume and Jason Martinez involving alleged injuries from exposure to the toxin TBP. The present opinion addressed only PATH’s reconsideration motion.

PATH’s arguments

PATH repeated arguments it had made in support of summary judgment. It argued that admissible expert testimony was necessary to establish general causation and dosage; that Dr. Fox’s testimony lacked a reliable basis; that the manufacturer’s safety data sheet for TBP was unreliable proof of general causation; and that the remaining evidence was legally insufficient to allow the case to proceed to a jury.

Court’s reasoning

The court explained that reconsideration is an extraordinary remedy and is usually denied. A party seeking reconsideration must identify an intervening change in controlling law, newly available evidence, or a need to correct clear error or prevent manifest injustice. A motion cannot be used simply to relitigate issues already decided.

The court found that PATH did not identify any recognized basis for reconsideration. Its motion repeated arguments rejected in the earlier order. The court also reaffirmed that, under Second Circuit law, a factfinder could reasonably determine without expert testimony that prolonged exposure to toxins caused the type of inhalation injuries alleged by the plaintiffs. The court further rejected PATH’s reliance on a prior toxic-tort decision involving the Jones Act, explaining that the Jones Act case involved a different federal statute and a more demanding causation standard.

Ruling

Chief Judge Colleen McMahon denied PATH’s motion for reconsideration. The clerk was directed to close the motion at Docket Number 38. The opinion did not revisit or alter the earlier order denying summary judgment.

The authoritative version

Read the full 3-page opinion on CourtListener, the free public archive maintained by the Free Law Project.

Open opinion PDF →
Summary written with AI assistance. See how summaries are made. Spot something wrong? Tell us.